Kyle Rusconi

Director at Gliknik.

Raised on Gliknik filings

$16.3M

of $21M offered across 2 Form D filings

Form D filings: 2
Teammates: 8
Last filing: Aug 21, 2025

Company

Biotech · Baltimore, MD

Fc fusion biologics for autoimmune disease and cancer

Fc fusion biologics for autoimmune disease and cancer

Investors: 25
Still open: $4.7M

Investors: 25
Sector: Biotech
HQ: Baltimore, MD

Gliknik filings

Gliknik Form D filings
Filed	Security	Sold of offered	Filing
Aug 21, 2025	Security to be acquired	$11M/ $15M	Form D
Jan 24, 2025	Security to be acquired	$5.3M/ $6M	Form D/A

Security to be acquiredFiled Aug 21, 2025Form D
$11M/ $15M
Security to be acquiredFiled Jan 24, 2025Form D/A
$5.3M/ $6M

Works with

Also named on Gliknik filings

David S. BlockCEO and President, Form D signerForm D signer David BroserDirector Paul A. FriedmanDirector Elizabeth C. BlockExecutive Officer Richard S. LevyDirector Charles PolskyDirector Paul FreidmanDirector Raymond SchinaziDirector